Cullinan Therapeutics, Inc. CGEM Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Cullinan Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The official record: Cullinan Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cullinan Therapeutics, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cullinan Therapeutics, Inc.'s total current assets?
- Cullinan Therapeutics, Inc. (CGEM) reported total current assets of $361.41M in Q1 2026.
- How has Cullinan Therapeutics, Inc.'s total current assets changed year-over-year?
- Cullinan Therapeutics, Inc.'s total current assets increased by 13.7% year-over-year, from $317.77M to $361.41M.
- What is the long-term trend for Cullinan Therapeutics, Inc.'s total current assets?
- Over 5 years (2020 to 2025), Cullinan Therapeutics, Inc.'s total current assets has grown at a 12.7% compound annual growth rate (CAGR), from $212.28M to $386.76M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.